|
Medical Marijuana Has A New Partner, CBD
CBD is cannabis’ best friend. Short for cannabidiol, CBD is the main component of marijuana that gives patients health benefits. CBD is non-psychoactive meaning it won’t get you high. With research being done on CBD’s myriad of health benefits including cancer-fighting, pain reducing, reducing seizures and a list of others, CBD is set to become the next great investment market.
Click Here Now To Read Article |
InMed Pharmaceuticals, Inc. (IMLFF) Announces Publication in European Journal of Pain
InMed Pharmaceuticals, Inc. (“InMed” or the “Company”) (CSE: IN; OTCQB: IMLFF), a biopharmaceutical company specializing in the research and development of novel, cannabinoid-based drug therapies, announced today the publication of company-sponsored research in the European Journal of Pain. The article, titled “Delta-9-tetrahydrocannabinol decreases masticatory muscle sensitization in female rats through peripheral cannabinoid receptor activation”, presents results from a study co-sponsored by InMed and the MITACS Elevate Postdoctoral Fellowship program. The study was conducted by Dr. Hayes Wong and Prof. Brian Cairns at the University of British Columbia and was co-authored by Dr. Sazzad Hossain , Chief Scientific Officer of InMed.
Click Here Now To Read (IMLFF) Release
|
|
Marijuana Stocks: How To Make a Profit There is no surefire number to making a profitable investment in any business, but when it comes to the extremely volatile, and profitable industry of marijuana, the potential for gains could be great in today’s climate. What many are finding is that the ebb and flow of marijuana stocks has created an opportunity to profit off of this booming green rush. This has also begun to attract thousands of new investors looking at marijuana stocks, both seasoned and green.
Click Here Now To Read Full Article |
|
MAPH owns “250,000” restricted common shares of InMed Pharmaceuticals. PLEASE READ OUR FULL PRIVACY POLICY & TERMS OF USE & DISCLAIMER
|
